These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1033750)

  • 1. The influence of cystamine on pharmacokinetics and pharmacodynamics of thioridazine.
    Wójciakowa Z; Kozaryn I
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):557-63. PubMed ID: 1033750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in pharmacodynamics and pharmacokinetics of psycholeptic drugs in the course of radiation disease. Effects of premedication with cystamine on dynamics and kinetics of thioridazine.
    Wójciak Z; Kozaryn I; Chodera A; Szczawińska K; Cenajek D
    Acta Physiol Pol; 1977; 28(2):169-78. PubMed ID: 868535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of psycholeptic drugs in the course of radiation disease.
    Kozaryn I; Wójciakowa Z; Chodera A; Szczawińska K; Cenajek D
    Acta Physiol Pol; 1977; 28(3):263-70. PubMed ID: 899817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cystamine on pharmacokinetics and pharmacodynamics of nitrazepam.
    Szczawińska K; Cenajek D
    Arch Immunol Ther Exp (Warsz); 1977; 25(2):157-62. PubMed ID: 869675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics and pharmacokinetics of psycholeptic drugs in the course of radiation disease. The effect of premedication with cystamine on pharmacodynamics and Pharmacokinetics of nitrazepam.
    Szczawińska K; Cenajek D; Chodera A; Wójciak Z; Okulicz-Kozaryn
    Acta Physiol Pol; 1977; 28(2):161-8. PubMed ID: 868534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cystamine on activity and biotransformation of hexobarbital.
    Kozaryn I; Wójciakowa Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(6):837-40. PubMed ID: 1220636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
    Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystamine effect on the pharmacokinetics of imipramine in radiation sickness.
    Cenajek D; Chodera A; Wójciak Z; Szczawińska K; Kozaryn I
    Acta Physiol Pol; 1980; 31(2):123-9. PubMed ID: 7395537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the effect of cystamine on imipramine metabolism in radiation sickness.
    Chodera A; Cenajek D; Wójciak Z; Szczawiínska K; Kozaryn I
    Acta Physiol Pol; 1980; 31(1):41-6. PubMed ID: 7376897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of o-nitroanisole in Fischer 344 rats.
    Miller MJ; Sipes IG; Perry DF; Carter DE
    Drug Metab Dispos; 1985; 13(5):527-31. PubMed ID: 2865097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thioridazine and diazepam on the pharmacokinetics of [14C]imipramine in rat: acute study.
    Beaubien AR; Mathieu LF; Coldwell BB
    J Pharm Pharmacol; 1975 Jul; 27(7):484-90. PubMed ID: 239152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption and excretion of thioridazine and mesoridazine in man.
    Charalampous KD; Johnson PC; Estevez V
    Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of peroxisomal beta-oxidation and brain development in rats.
    Van den Branden C; Dacremont G; Hooghe R; Roels F
    Glia; 1989; 2(4):260-5. PubMed ID: 2527823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
    Garrigou-Gadenne D; Durand A; Thenot JP; Morselli PL
    Drug Metab Dispos; 1991; 19(3):574-9. PubMed ID: 1680622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic cystamine treatment inhibits small artery remodelling in rats.
    Eftekhari A; Rahman A; Schaebel LH; Chen H; Rasmussen CV; Aalkjaer C; Buus CL; Mulvany MJ
    J Vasc Res; 2007; 44(6):471-82. PubMed ID: 17657163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioridazine-fluoxetine interaction at the level of the distribution process in vivo.
    Wójcikowski J; Daniel WA
    Pol J Pharmacol; 2002; 54(6):647-54. PubMed ID: 12866720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.